Skip to main content

APOGEE ENTERPRISES, INC.

For the period ended Aug 29, 2026. Filed Oct 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Aug 29, 2026 · Filed Oct 6, 2026

APOG$48.05+5.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

Six Months Ended
(In thousands)August 29, 2026August 30, 2025
Operating Activities
Net earnings$33,917$20,962
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization26,56924,943
Share-based compensation4,9272,773
Deferred income taxes3,49417,214
Impairment of long-lived assets—7,418
Settlement of New Markets Tax Credit transaction—(4,597)
Non-cash lease expense6,0645,474
Other, net4,1374,129
Changes in operating assets and liabilities:
Receivables4,666(9,204)
Inventories(9,931)(9,735)
Contract assets(9,379)10,518
Accounts payable(15,576)(2,575)
Accrued compensation and benefits2,971(9,681)
Contract liabilities(1,621)15,734
Operating lease liability(6,952)(4,608)
Accrued income taxes2,426(11,008)
Other current assets and liabilities(2,453)(20,477)
Net cash provided by operating activities43,25937,280
Investing Activities
Capital expenditures(17,796)(11,827)
Purchases of marketable securities(7,418)(200)
Acquisition of business, net of cash acquired(99,574)—
Other, net2,9571,144
Net cash used in investing activities(121,831)(10,883)
Financing Activities
Proceeds from revolving credit facilities161,00076,000
Repayment on revolving credit facilities(54,867)(91,000)
Repayment of term loans(2,867)—
Repurchase of common stock(16,099)—
Dividends paid(11,175)(11,043)
Other, net(1,117)(3,087)
Net cash provided by (used in) financing activities74,875(29,130)
Effect of exchange rates on cash702811
Decrease in cash and cash equivalents(2,994)(1,922)
Cash and cash equivalents at beginning of period39,52341,448
Cash and cash equivalents at end of period$36,529$39,526
Non-cash Activity
Capital expenditures in accounts payable$1,348$2,202
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.